Changes

==== Cautions for purification treatments ====

==== Cautions for purification treatments ====

[[Panchakarma]]( therapeutic purification) treatments are indicated only in strong patients with excess aggravation of doshas in rajayakshma. In a patient with low strength, purification is not done. If at all, it needs to be done due to excess dosha, then mild purification is prescribed after taking every care of strength of the patient.  

[[Panchakarma]]( therapeutic purification) treatments are indicated only in strong patients with excess aggravation of ''doshas'' in ''rajayakshma''. In a patient with low strength, purification is not done. If at all, it needs to be done due to excess ''dosha'', then mild purification is prescribed after taking every care of strength of the patient.  

Role of rasayana in enhancing the immunity:

 

Rasayana drugs have got an important role in the management of rajayakshma. Mandagni (at the level of jatharagni and dhatwagni both) and srotovarodha play an important role in the pathogenesis of this disease. Rasayana drugs act at various levels to promote nutrition. Some of them work at the level of rasa (enriching nutrient plasma) while others work at the level of agni (improve digestion and metabolism). Some other work at the level of srotas by promoting the competence of microcirculatory channels in the body leading to better bio-availability of nutrients to the tissues and improved tissue perfusion.[2] Hence, rasayana acting at all three levels may prove beneficial in the management of rajayakshma. Rasayana drugs also improve the status of ojas in the body by their immunomodulatory action. Thus these drugs are used as an adjuvant to anti-tubercular drugs and they enhance efficacy of treatment at various levels. Details about rasayana drugs have already been described in first chapter of chikitsa section.  Nidana parivarjan (removal of the causes) is yet another aspect of treatment.

==== Role of ''rasayana'' in enhancing the immunity ====

Research on ayurveda treatment in tuberculosis patients:

 

As we look back to the history of tuberculosis treatment, the immune-boost up was the main treatment. Ayurvedic treatment of tuberculosis was initiated in 1933 by the establishment of Patipukur TB Hospital, Kolkata. Later on, a full-fledged research unit was commissioned with exclusive budget. Treatment guidelines were adopted on Ayurvedic principles for therapeutic management which was a unique effort of its kind in pre-independence India. This regimen was discontinued from 1st November 1947 on the introduction of synthetic ATDs. Drugs containing mercury, gold, calcium was prepared at the in-house pharmacy and was administered to the patients with fresh juice of herbs cultivated in the hospital garden. Formulations like vasantamalati, kanchanabhra rasa, rajamriganka rasa were under use including bhallataka (Semicarpus anacardium) rasayan, mallasindura, vasa (Adatoda vasica) etc. The statistics on the treatment of pulmonary tuberculosis using Ayurvedic medicine for over a period of 13 years is of immense value.[1]

''Rasayana'' drugs have got an important role in the management of ''rajayakshma''. ''Mandagni'' (at the level of ''jatharagni'' and ''dhatvagni'' both) and ''srotovarodha'' play an important role in the pathogenesis of this disease. ''Rasayana'' drugs act at various levels to promote nutrition. Some of them work at the level of ''rasa'' (enriching nutrient plasma) while others work at the level of ''agni'' (improve digestion and metabolism). Some other work at the level of ''srotas'' by promoting the competence of microcirculatory channels in the body leading to better bio-availability of nutrients to the tissues and improved tissue perfusion.[2] Hence, ''rasayana'' acting at all three levels may prove beneficial in the management of ''rajayakshma''. ''Rasayana'' drugs also improve the status of ''ojas'' in the body by their immunomodulatory action. Thus these drugs are used as an adjuvant to anti-tubercular drugs and they enhance efficacy of treatment at various levels. Details about ''rasayana'' drugs have already been described in first chapter of [[Chikitsa Sthana]].  ''Nidana parivarjana'' (removal of the causes) is yet another aspect of treatment.

 

==== Research on Ayurveda treatment in tuberculosis patients ====

 

As we look back to the history of tuberculosis treatment, the immune-boost up was the main treatment. Ayurvedic treatment of tuberculosis was initiated in 1933 by the establishment of Patipukur TB Hospital, Kolkata. Later on, a full-fledged research unit was commissioned with exclusive budget. Treatment guidelines were adopted on Ayurvedic principles for therapeutic management which was a unique effort of its kind in pre-independence India. This regimen was discontinued from 1st November 1947 on the introduction of synthetic ATDs. Drugs containing mercury, gold, calcium was prepared at the in-house pharmacy and was administered to the patients with fresh juice of herbs cultivated in the hospital garden. Formulations like vasantamalati'', kanchanabhra rasa, rajamriganka rasa'' were under use including ''bhallataka'' (Semicarpus anacardium) rasayana'', mallasindura, vasa'' (Adatoda vasica) etc. The statistics on the treatment of pulmonary tuberculosis using Ayurvedic medicine for over a period of 13 years is of immense value.[1]

 

Research outcome relevant for public health from the Indian systems of medicine on tuberculosis at The Patipukur TB Hospital: Modern TB-drugs were administered to about 2766 patients and the cure rate turned out to be 11.42% and the death rate 40.9%. When a group of patients on modern anti-TB drugs received supplementary Ayurvedic drugs, the cure rate was 41.3% and the death rate was 3.8%. Studies have also been conducted to assess the role of Ayurvedic treatment in resistant cases. [1]

Research outcome relevant for public health from the Indian systems of medicine on tuberculosis at The Patipukur TB Hospital: Modern TB-drugs were administered to about 2766 patients and the cure rate turned out to be 11.42% and the death rate 40.9%. When a group of patients on modern anti-TB drugs received supplementary Ayurvedic drugs, the cure rate was 41.3% and the death rate was 3.8%. Studies have also been conducted to assess the role of Ayurvedic treatment in resistant cases. [1]

References:

 

1. Shailaja C. Journal of Health & Population in Developing Countries. Vol. 3. WHO publication; 2000.A few research outcomes relevant for Public Health from Indian System of Medicine; p. 109.

=== References ===

2. Singh, RH and Rastogi, S. Rasayana Therapy and Rejuvenation. In Evidence based practice of CAM,  PP 177-190. Springer, Germany. 2012

#Shailaja C. Journal of Health & Population in Developing Countries. Vol. 3. WHO publication; 2000.A few research outcomes relevant for Public Health from Indian System of Medicine; p. 109.

#Singh, RH and Rastogi, S. Rasayana Therapy and Rejuvenation. In Evidence based practice of CAM,  PP 177-190. Springer, Germany. 2012